Knowledge of hepatitis B and C prevalence, and numbers infected, are important for
planning responses. Published HBsAg and anti-HCV prevalences for the 20 WHO European …

To replicate their genomes in cells and generate new progeny, viruses typically require
factors provided by the cells that they have infected. Subversion of the cellular machinery …

ABSTRACT BMS-790052, targeting nonstructural protein 5A (NS5A), is the most potent
hepatitis C virus (HCV) inhibitor described to date. It is highly effective against genotype 1 …

Hepatitis C virus (HCV) is a major public health concern globally, resulting in liver-related
complications. Approximately 6% population of Pakistan is infected with HCV. HCV is error …

The re-emerging Zika virus (ZIKV) is an arthropod-borne virus that has been described to
have explosive potential as a worldwide pandemic. The initial transmission of the virus was …

PEGylation is the covalent conjugation of PEG to therapeutic molecules. Protein PEGylation
is a clinically proven approach for extending the circulation half-life and reducing the …

Epigallocatechin-3-gallate (EGCG) is the most abundant catechin in green tea. In this study,
we found that hepatitis C virus (HCV) infection was significantly suppressed by EGCG in an …

Emerging infectious diseases pose a serious threat to public health security; this is
especially true in the underdeveloped world because of limited resources to combat them …

Although hepatitis C virus (HCV) affects approximately 130-170 million people worldwide,
no vaccines are available. HCV is an important cause of chronic hepatitis, cirrhosis and …

The introduction of highly potent direct‐acting antivirals (DAAs) has revolutionized hepatitis
C virus treatment. Nevertheless, viral eradication worldwide remains a challenge also in the …